An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis-Reference-Cited by-同舟云学术

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis

Published:2023-03-04 Issue:4 Volume:24 Page:495-509
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Dumitrescu Laura¹²,Papathanasiou Athanasios³,Coclitu Catalina⁴,Garjani Afagh⁵,Evangelou Nikos³⁵,Constantinescu Cris S.⁵⁶,Popescu Bogdan Ovidiu¹²,Tanasescu Radu³⁵

Affiliation:

1. Department of Clinical Neurosciences, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

2. Department of Neurology, Colentina Clinical Hospital, Bucharest, Romania

3. Department of Neurology, Queen’s Medical Centre, Nottingham University Hospitals, Nottingham, UK

4. Department of Multiple Sclerosis and Neuroimmunology, CHU Grenoble, Grenoble, France

5. Academic Clinical Neurology, Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK

6. Department of Neurology, Cooper Neurological Institute, Camden, NJ, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2178898

Reference104 articles.

1. Defining the clinical course of multiple sclerosis: The 2013 revisions

2. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

3. MS T. How common is MS? [cited 2022 Aug 1]. Available from: https://mstrust.org.uk/a-z/how-common-multiple-sclerosis

4. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

5. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell trafficking in human chronic inflammatory diseases;iScience;2024-08

2. Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08

3. Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications;Neuroscience;2024-06

4. Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-05-23

5. Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series;Journal of Neurology;2024-04-02